Flag of the European Union EU Clinical Trials Register Help

Clinical trials

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44394   clinical trials with a EudraCT protocol, of which   7406   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    44,394 result(s) found. Displaying page 63 of 2,220.
    «« First « Previous 59  60  61  62  63  64  65  66  67  Next» Last»»
    EudraCT Number: 2007-005717-19 Sponsor Protocol Number: Lakritsi001 Start Date*: 2007-12-04
    Sponsor Name:Oulu University Hospital Department of Internal Medicine
    Full Title: Lakritsin ja tiatsididiureetin yhteiskäytön vaikutus kaliumpitoisuuteen
    Medical condition: Terveitä vapaaehtoisia
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-011004-33 Sponsor Protocol Number: V78_07S Start Date*: 2009-06-09
    Sponsor Name:Novartis Vaccines and Diagnostics GmbH & Co. KG
    Full Title: A Phase II, single center, uncontrolled, open label study to evaluate safety and immunogenicity of FLUVIRIN® [Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur], Formulation 2009/2010, when A...
    Medical condition: Prophylaxis of influenza
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-011008-43 Sponsor Protocol Number: CRAD001AIT16 - EVERHEART Start Date*: 2009-06-24
    Sponsor Name:NOVARTIS FARMA
    Full Title: Early vs.delayed EVERolimus in de novo HEART transplant recipients: optimozation of the safety/efficacy profile (EVERHEART Study)
    Medical condition: de novo heart transplant patients
    Disease: Version SOC Term Classification Code Term Level
    9.1 10028593 Myocardial disorders HLGT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-011013-24 Sponsor Protocol Number: AC-063A302 Start Date*: 2009-06-03
    Sponsor Name:Actelion Pharmaceuticals Ltd.
    Full Title: A Multicenter, Double-blind, Randomized Study comparing the Safety and Tolerability of Iloprost inhalation solution delivered by I-neb utilizing Power disc-15 and Power disc-6 in Patients with Symp...
    Medical condition: Indication: Symptomatic Pulmonary Arterial Hypertension
    Disease: Version SOC Term Classification Code Term Level
    9.1 10064911 Pulmonary arterial hypertension LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2009-011017-24 Sponsor Protocol Number: ADNC-0726 Start Date*: 2009-08-03
    Sponsor Name:LFB Biotechnologies
    Full Title: A Phase II, open-label, randomised, dose-finding study to compare the efficacy (in terms of clearance of RhD-positive RBCs) and safety of LFB-R593, a monoclonal anti-RhD antibody, vs Rhophylac®, a ...
    Medical condition: Prophyllaxis against RhD isoimmunisation during pregnancy (anti-D prophylaxis) Treatment of RhD negative individuals after incompatible transfusions with blood components containing RhD-positive r...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019513 Hemolytic disease of fetus or newborn, due to isoimmunization LLT
    9.1 10044360 Transfusion with incompatible blood LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-011036-36 Sponsor Protocol Number: C-01-78 Start Date*: 2009-05-07
    Sponsor Name:Alcon Research, Ltd.
    Full Title: Estudio multicéntrico de la pigmentación en la red trabecular después de dos años de tratamiento con TRAVATAN 0,004% solución oftálmica. A multicenter study of the pigmentation in the trabecular me...
    Medical condition: Glaucoma de angulo abierto o hiperstensión ocular. Open-angle glaucoma or ocular hypertension
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030348 Open angle glaucoma LLT
    9.1 10030043 Ocular hypertension LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-007644-34 Sponsor Protocol Number: ML25033 Start Date*: 2009-02-23
    Sponsor Name:Asociación Terapeutica en Hematologia y Oncología Médicas
    Full Title: Estudio de fase II, multicéntrico, abierto, aleatorizado, de tratamiento secuencial con docetaxel y erlotinib intermitente frente a erlotinib en pacientes con carcinoma no microcítico de pulmón loc...
    Medical condition: Carcinoma no microcítico de pulmón localmente avanzado o metastásico, tras fracaso a un tratamiento quimioterápico previo.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-013054-33 Sponsor Protocol Number: V72P6E1 Start Date*: 2009-08-18
    Sponsor Name:Novartis Vaccines and Diagnostics Srl.
    Full Title: A Phase 2, Open-Label, Single-Center, Extension Study Evaluating Antibody Persistence compared to Naïve Children and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV N...
    Medical condition: The Novartis Meningococcal B recombinant vaccine is intended for prevention of meningitis and/or septicemia caused by Neisseria meningitidis serogroup B. The objective of the Novartis Meningococcal...
    Disease:
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-013062-11 Sponsor Protocol Number: AR-OCUL-1 Start Date*: 2007-03-29
    Sponsor Name:AZIENDA USL 8 AREZZO
    Full Title: BEVACIZUMAB COMBINED WITH PDT, VERSUS RANIBIZUMAB AND PEGAPTANIB BOTH COMBINED WITH PDT FOR NEOVACULAR AGE RELATED MACULAR DEGENERATION CLINICAL TRIAL
    Medical condition: Neovascular Age Related Macular Degeneration
    Disease: Version SOC Term Classification Code Term Level
    9.1 10015902 Exudative senile macular degeneration of retina LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-006249-42 Sponsor Protocol Number: D5252C00008 Start Date*: 2008-02-28
    Sponsor Name:AstraZeneca AB
    Full Title: A Phase 3, randomised, open-label, cross-over study to compare HFA vs CFC pMDI formulations of budesonide on methacholine hyper-reactivity in patients with stable, persistent, mild to moderate asthma
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003553 Asthma LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-001504-37 Sponsor Protocol Number: 30/2006/O/Sper Start Date*: 2006-05-18
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: SUBCUTANEOUS INOCULATION OF ALLOGENEIC GENE-MODIFIED TUMOR CELLS ACHN-IL2 MIXED TO AUTOLOGOUS TUMOR CELLS CT-AUT IN PATIENTS WITH METASTATIC RENAL CARCINOMA.
    Medical condition: Metastatic Kidney Cancer
    Disease: Version SOC Term Classification Code Term Level
    6.1 10050018 PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-001509-26 Sponsor Protocol Number: DESG-01 Start Date*: 2006-10-11
    Sponsor Name:Dermal Laboratories Limited
    Full Title: An open evaluation of an emollient shower gel for dry skin conditions.
    Medical condition: Dry or chapped skin conditions which may also be pruritic (itchy) or inflamed e.g. eczema, psoriasis, elderly pruritus and dermatitis.
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-001510-32 Sponsor Protocol Number: MP432 Start Date*: 2006-09-01
    Sponsor Name:Meda Pharmaceuticals
    Full Title: Active-Controlled Trial of the Safety of MP03-33 in Patients with Chronic Allergic or Nonallergic Rhinitis
    Medical condition: Chronic Allergic or Nonallergic Rhinitis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039083 LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2006-001515-29 Sponsor Protocol Number: 11492A Start Date*: 2006-07-10
    Sponsor Name:H. Lundbeck A/S
    Full Title: Double-blind, randomised, placebo-controlled study comparing the efficacy and safety of two fixed dosages of a novel antidepressant compound to that of placebo in patients with Major Depressive Dis...
    Medical condition: Major Depressive Disorder
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed) SE (Completed) ES (Completed) AT (Completed) SK (Completed) CZ (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-015118-23 Sponsor Protocol Number: DASA-TRAS Start Date*: 2010-01-05
    Sponsor Name:GETH
    Full Title: ESTUDIO PILOTO FASE II MULTICÉNTRICO, NO ALEATORIZADO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE DASATINIB TRAS TRASPLANTE ALOGÉNICO DE PROGENITORES HEMOPOYÉTICOS EN PACIENTES CON LEUCEMIA AGUDA LINFO...
    Medical condition: Evaluar la eficacia del mantenimiento con dasatinib en términos de Supervivencia Libre de Enfermedad a 2 años, estimado según curvas de Kaplan-Meier, en pacientes con Leucemia Linfoblástica Aguda P...
    Disease: Version SOC Term Classification Code Term Level
    12.0 10024338 Leukemia lymphoblastic acute LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-015136-14 Sponsor Protocol Number: FP-0110-201 Start Date*: 2009-11-20
    Sponsor Name:FORMAC Pharmaceuticals NV
    Full Title: Modified release metronidazole for the treatment of pouchitis after colectomy with ileo-anal pouch anastomosis for ulcerative colitis: a pharmacokinetic study
    Medical condition: Pouchitis
    Disease: Version SOC Term Classification Code Term Level
    12.0 10036463 Pouchitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-015158-39 Sponsor Protocol Number: SAG-51/DIV Start Date*: 2010-05-06
    Sponsor Name:Dr. Falk Pharma GmbH
    Full Title: Double-blind, dose-response, randomised, placebo-controlled, parallel group, multicentre phase III clinical study on the efficacy and tolerability of mesalazine granules vs. placebo for the prevent...
    Medical condition: Diverticulitis
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021881 - Infections and infestations 10013538 Diverticulitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended) FI (Prematurely Ended) BE (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended) GR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-011212-37 Sponsor Protocol Number: RD.03.SPR.29084 Start Date*: 2010-01-06
    Sponsor Name:Galderma research & Development
    Full Title: Anti P. acnes activity of Epiduo® Gel compared to Benzoyl Peroxide 2.5% Gel in the treatment of subjects with acne vulgaris
    Medical condition: Acne vulgaris with a high level of P. Acnes on the face (obeserved under wood's lamp)
    Disease: Version SOC Term Classification Code Term Level
    12.0 10000519 Acne vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2009-011220-62 Sponsor Protocol Number: 80-82310-98-09098 Start Date*: 2009-10-26
    Sponsor Name:University Medical Center Utrecht
    Full Title: A randomized controlled withdrawal trial in Crohn's disease patients in long-term remission on mesalazine: the CROWN study
    Medical condition: 1. Patients with a diagnosis of quiscent (CDAI < 150) Crohn's Disease (CD) according to established clinical, endoscopic, radiological and histological criteria. 2. Patients will be aged 18 years ...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10011401 Crohn's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-011296-80 Sponsor Protocol Number: CSPP100AFR01 Start Date*: 2009-06-10
    Sponsor Name:Novartis Pharma S.A.S
    Full Title: Efficacy of Rasilez® (Aliskiren) compared to ramipril in the treatment of moderate systolic hypertensive patients
    Medical condition: Hypertension artérielle systolique
    Disease: Version SOC Term Classification Code Term Level
    9.1 10042957 Systolic hypertension LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 59  60  61  62  63  64  65  66  67  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 15 16:36:09 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA